The Delivery of mRNA Vaccines for Therapeutics

43Citations
Citations of this article
112Readers
Mendeley users who have this article in their library.

Abstract

mRNA vaccines have been revolutionary in combating the COVID-19 pandemic in the past two years. They have also become a versatile tool for the prevention of infectious diseases and treatment of cancers. For effective vaccination, mRNA formulation, delivery method and composition of the mRNA carrier play an important role. mRNA vaccines can be delivered using lipid nanoparticles, polymers, peptides or naked mRNA. The vaccine efficacy is influenced by the appropriate delivery materials, formulation methods and selection of a proper administration route. In addition, co-delivery of several mRNAs could also be beneficial and enhance immunity against various variants of an infectious pathogen or several pathogens altogether. Here, we review the recent progress in the delivery methods, modes of delivery and patentable mRNA vaccine technologies.

Cite

CITATION STYLE

APA

Nitika, Wei, J., & Hui, A. M. (2022, August 1). The Delivery of mRNA Vaccines for Therapeutics. Life. MDPI. https://doi.org/10.3390/life12081254

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free